Search results for "DEFICIENCY"

showing 10 items of 1071 documents

Persistent SARS-CoV-2 infection with repeated clinical recurrence in a patient with common variable immunodeficiency

2021

This work was co-financed by the European Union through the Operational Programme of the European Regional Development Fund of Valencia Region (Spain) 2014–2020.

Microbiology (medical)2019-20 coronavirus outbreakCoronavirus disease 2019 (COVID-19)SARS-CoV-2business.industryCommon variable immunodeficiencySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)COVID-19General Medicinemedicine.diseaseVirologyCommon Variable ImmunodeficiencyInfectious DiseasesClinical recurrencemedicineHumansbusinessLetter to the EditorPulmons Malalties
researchProduct

Oral leishmaniasis in an HIV-infected patient.

2000

As in most countries in the Mediterranean basin, leishmaniasis is endemic in Italy, where it has visceral (VL) and cutaneous (CL) forms caused by viscerotropic and dermotropic strains of Leishmania infantum, respectively. With the spread of the acquired immunodeficiency syndrome (AIDS) epidemic, the number of coinfections with Leishmania and human immunodeficiency virus (HIV) is increasing. Between 35% and 50% of the adult VL cases diagnosed annually in Sicily from 1991 to 1995 were related to HIV [1]; although cases of coinfection have been reported in 28 countries worldwide, the majority of these cases (1440 from 1990 to 1998) have been notified in four countries (Spain, Italy, France, Po…

Microbiology (medical)AdultLeishmaniasis MucocutaneousMaleHIV InfectionsAcquired immunodeficiency syndrome (AIDS)medicineHumansSidaLeishmaniasisbiologyLamivudineLeishmaniasisGeneral MedicineMiddle Agedmedicine.diseasebiology.organism_classificationLeishmaniaVirologyInfectious DiseasesImmunologyCoinfectionFemaleViral diseaseLeishmania infantumMouth Diseasesmedicine.drugEuropean journal of clinical microbiologyinfectious diseases : official publication of the European Society of Clinical Microbiology
researchProduct

Meningitis due to Pseudomonas stutzeri in a patient infected with human immunodeficiency virus.

1996

Microbiology (medical)AdultMalebiologyAIDS-Related Opportunistic Infectionsbusiness.industrybiology.organism_classificationmedicine.diseaseVirologyMicrobiologyPseudomonas stutzeriMeningitis BacterialInfectious DiseasesAcquired immunodeficiency syndrome (AIDS)ImmunopathologyPseudomonasPseudomonadalesMedicineHumansPseudomonas InfectionsViral diseasebusinessSidaMeningitisPseudomonadaceaeClinical infectious diseases : an official publication of the Infectious Diseases Society of America
researchProduct

Recent acquired STD and the use of HAART in the Italian Cohort of Naive for Antiretrovirals (I.Co.N.A): analysis of the incidence of newly acquired h…

2008

Objective: To estimate the incidence of newly acquired syphilis (n-syphilis) and hepatitis B infection (n-hepatitis B) in I.Co.N.A. and to evaluate the impact of HAART, calendar date and risk group. Methods: Cohort study: Incidence was calculated by person-years analyses. Poisson regression was used for the multivariate model. Results: The rate of n-syphilis was 23.4/1,000 PYFU and it increased over time; HIV transmission risk was the most important predictor: men who have sex with men (MSM) had a considerable higher risk (RR 5.92, 95% CI 2.95-12.13 vs IDU/exIDU, p < 0.0001). The rate of n-hepatitis B was 12.2/1,000 PYFU; it declined in recent years and halved per 10 years age. Patients wit…

Microbiology (medical)AdultMalemedicine.medical_specialtyHBsAgHAARTPopulationImmunologySexually Transmitted DiseasesHIV InfectionsLower riskRegression AnalysiMen who have sex with menCohort StudiesAcquired immunodeficiency syndrome (AIDS)Internal medicineAntiretroviral Therapy Highly ActivemedicineHumansHIV InfectionPoisson DistributionSyphilisHomosexuality MaleeducationMultivariate AnalysiSexually Transmitted Diseaseeducation.field_of_studybusiness.industryIncidence (epidemiology)Incidencevirus diseasesHIVGeneral MedicineHepatitis Bmedicine.diseaseHepatitis BInfectious DiseasesSyphiliItalyImmunologyCohortMultivariate AnalysisHIV-1Regression AnalysisFemaleCohort StudiebusinessHumanInfection
researchProduct

Iron regulatory mechanisms in Saccharomyces cerevisiae

2020

Iron is an essential micronutrient for all eukaryotic organisms because it participates as a redox cofactor in many cellular processes. However, excess iron can damage cells since it promotes the generation of reactive oxygen species. The budding yeast Saccharomyces cerevisiae has been used as a model organism to study the adaptation of eukaryotic cells to changes in iron availability. Upon iron deficiency, yeast utilizes two transcription factors, Aft1 and Aft2, to activate the expression of a set of genes known as the iron regulon, which are implicated in iron uptake, recycling and mobilization. Moreover, Aft1 and Aft2 activate the expression of Cth2, an mRNA-binding protein that limits t…

Microbiology (medical)DNA damageSaccharomyces cerevisiaelcsh:QR1-502Saccharomyces cerevisiaeMicroorganismesyeastMicrobiologylcsh:Microbiology03 medical and health sciencesTranscriptional regulationiron deficiencyFongsiron metabolismPost-transcriptional regulationTranscription factorGene030304 developmental biology0303 health sciencesbiology030306 microbiologyChemistryPost-transcriptional regulationiron excessbiology.organism_classificationYeastCell biologyCytosolReguloniron homeostasisFerro
researchProduct

A case of spotted fever rickettsiosis in a human immunodeficiency virus-positive patient.

2013

Microbiology (medical)DNA BacterialMaleHuman Immunodeficiency Virus Positivebusiness.industryCoinfectionHIV InfectionsGeneral MedicineExanthemaMiddle Agedmedicine.diseaseBoutonneuse FeverMicrobiologyVirologyHepatitis CSpotted feverRickettsia conoriiRickettsiosisTick-Borne DiseasesDoxycyclineImmunologymedicineHumansbusinessJournal of medical microbiology
researchProduct

Producción científica, colaboración y ámbitos de investigación en Enfermedades Infecciosas y Microbiología Clínica (2003–2007)

2010

Introduction: Collaboration is essential for biomedical research. The Carlos III Health Institute (the Spanish national public organization responsible for promoting biomedical research) has encouraged scientific collaboration by promoting Thematic Networks and Cooperative Research Centres. Scientific collaboration in Enfermedades Infecciosas y Microbiologia Clinica journal is investigated. Methods: Papers published in Enfermedades Infecciosas y Microbiologia Clinica in the period 2002-2007 have been identified. Bibliometrics and Social Network Analysis methods have been carried out in order to quantify and characterise scientific collaboration and research areas. Results: A total of 805 pa…

Microbiology (medical)GerontologyPublic organizationResearch groupsbusiness.industryResearch areasCooperative researchHuman immunodeficiency virus (HIV)Library scienceBibliometricsmedicine.diseasemedicine.disease_causeAcquired immunodeficiency syndrome (AIDS)MedicinebusinessCitationEnfermedades Infecciosas y Microbiología Clínica
researchProduct

Tumornekrosefaktor und Interferon als prognostische Marker der HIV-Infektion

1991

Peripheral blood cells were obtained from patients at different stages of their human immunodeficiency virus (HIV) infection. It was found that the capacity to generate interferon alpha was reduced already at Walter Reed stage 2 (WR) while the interferon gamma capacity remained largely unaffected until WR stage 4. Endogenous tumor necrosis factor (TNF) alpha production increased as the HIV disease progressed. The data obtained add to our knowledge on destruction of the immune system by the HIV. Moreover TNF and acid labile interferon alpha might contribute to HIV replication and disease progression. Nevertheless the tests performed are too time-consuming to be introduced into routine analys…

Microbiology (medical)Human immunodeficiency virus (HIV)Alpha (ethology)Alpha interferonEndogenyGeneral MedicineBiologymedicine.disease_causeVirologyInfectious DiseasesImmune systemInterferonImmunologymedicineTumor necrosis factor alphaInterferon gammamedicine.drugInfection
researchProduct

Diagnosis of human immunodeficiency virus (HIV) infection: multicenter evaluation of a newly developed anti-HIV 1 and 2 enzyme immunoassay.

1994

A new anti-human immunodeficiency virus type 1 and 2 (anti-HIV 1 and 2) test is described. It uses recombinant p24 and peptides covering gp32, gp41, and gp120 to identify HIV-1 and HIV-2 infections. This test has been shown to be specific (99.5%) and sensitive (99.8%). In this respect, the assay was equal or superior to anti-HIV 1 and 2 tests run as references. The test was able to discriminate sera from patients with HIV infections from those from uninfected individuals with excellence; it also exerted high intra- and interassay precisions. The "modular" concept of the test allows the use of single components (gp32 or gp41) to separate between HIV-2 and HIV-1 infections, respectively.

Microbiology (medical)MaleHIV AntigensHIV InfectionsHIV AntibodiesGp41Sensitivity and SpecificityVirusDiagnosis DifferentialImmunoenzyme TechniquesAcquired immunodeficiency syndrome (AIDS)PregnancyImmunopathologyHIV SeropositivityMedicineHumansSidamedicine.diagnostic_testbiologybusiness.industryvirus diseasesmedicine.diseasebiology.organism_classificationVirologyRecombinant ProteinsHIV AntigensEvaluation Studies as TopicImmunoassayImmunologyHIV-2HIV-1FemaleViral diseasebusinessResearch ArticleJournal of clinical microbiology
researchProduct

Molecular Diagnosis of Toxoplasmosis in Immunocompromised Patients: a 3-Year Multicenter Retrospective Study

2015

ABSTRACT Toxoplasmosis is a life-threatening infection in immunocompromised patients (ICPs). The definitive diagnosis relies on parasite DNA detection, but little is known about the incidence and burden of disease in HIV-negative patients. A 3-year retrospective study was conducted in 15 reference laboratories from the network of the French National Reference Center for Toxoplasmosis, in order to record the frequency of Toxoplasma gondii DNA detection in ICPs and to review the molecular methods used for diagnosis and the prevention measures implemented in transplant patients. During the study period, of 31,640 PCRs performed on samples from ICPs, 610 were positive (323 patients). Blood ( n …

Microbiology (medical)Microbiological Techniquesmedicine.medical_specialtyMESH: Molecular Diagnostic TechniquesAsymptomaticPolymerase Chain Reactionlaw.inventionImmunocompromised Host[SDV.MHEP.MI]Life Sciences [q-bio]/Human health and pathology/Infectious diseaseslawInternal medicinemedicineMESH: Immunocompromised HostPrevalenceHumansComputingMilieux_MISCELLANEOUSPolymerase chain reactionImmunodeficiencySurvival analysisMESH: PrevalenceRetrospective Studies[SDV.EE.SANT]Life Sciences [q-bio]/Ecology environment/HealthMESH: Humansbusiness.industryIncidence (epidemiology)MESH: ToxoplasmaMESH: Microbiological TechniquesRetrospective cohort studyMESH: Polymerase Chain ReactionMESH: Retrospective Studiesmedicine.diseaseSurvival AnalysisToxoplasmosis3. Good healthSurgeryMESH: France[SDV.MP]Life Sciences [q-bio]/Microbiology and ParasitologyMolecular Diagnostic TechniquesMESH: Survival AnalysisChemoprophylaxisMESH: ToxoplasmosisParasitologyFrancemedicine.symptombusinessToxoplasmaToxoplasmosis
researchProduct